Interestingly, in the blood, patients with high-expression S100A12 were more likely to have lower scores of B cells, CD8 T cells, Th1 cells, Th2 cells, tumor infiltrates lymphocytes (TIL), and check point (Supplementary Figure 10). Here, S100A12 is linked to neoplasm.